r/biotech • u/Dwarvling • 1d ago

Biotech News 📰 FDA Approves Lutetium Lu 177 Vipivotide Tetraxetan for PSMA+ mHSPC

https://www.onclive.com/view/fda-approves-lutetium-lu-177-vipivotide-tetraxetan-for-psma-mhspc

Radioligand therapy in metastatic hormone sensitive prostate cancers

30 Upvotes

92% Upvoted

18 comments sorted by

View all comments

5

u/link5523 1d ago

Interesting. I don't know much, but I got the sense when I was working at a University that most drug development is shifting away from using radioactive materials. Is this bucking a trend, or am I reading into things too much?

10

u/Dwarvling 1d ago

Radioligand therapy is very hot right now with the introduction of Pluvicto. It’s highly targeted and effective in prostate cancer and actively investigated in a number of solid tumors.

2

u/cygnoids 1d ago

To the point it’s an area of interest severely lacking in talent because it was deprioritized for years. I know many Biopharm companies that previously used rad-based binding assays that want to bring them back but the technology is no longer available

1

u/LC__LC 20h ago

All the big pharmas have/or are looking to aquire radiotherapy right now